Nektar Therapeutics | NKTR - 借入資本





借入資本 変化する 日付
Agios Pharmaceuticals USD 1.06M 0 2022-09
ALKERMES USD 1.48B 1.2B 2026-03
Alterity Therapeutics Limited AUD 43.68K 59.53K 2025-12
Amgen USD 51.89B 1.88B 2026-03
Baxter International USD 8.62B 852M 2026-03
BioCryst Pharmaceuticals USD 395.2M 33.48M 2026-03
Biogen USD 6.29B 1.7M 2026-03
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Cara Therapeutics USD 0 0 2025-03
Cipla INR 3.82B 840.2M 2026-03
Dr.Reddys Laboratories INR 12.2B 595M 2026-03
Eisai JPY 134.78B 12M 2026-03
Eli Lilly USD 39.37B 1.5B 2026-03
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Gilead Sciences USD 20.86B 1.27B 2026-03
GlaxoSmithKline GBP 14.01B 696M 2026-03
Grifols EUR 9.95B 722.93M 2025-12
Halozyme Therapeutics USD 1.94B 206.73M 2026-03
Incyte USD 29.41M 785K 2026-03
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
MacroGenics USD 70M 256K 2025-12
Merck USD 46.67B 77M 2026-03
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 37.45B 7.86B 2026-03
Pfizer USD 60.57B 1.08B 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
Takeda JPY 4.37T 99.51B 2026-03
Teva Pharmaceutical Industries USD 14.02B 971M 2026-03
Xencor USD 82.12M 5.64M 2026-03